Provided sample report
Tirzepatide 30 mg
Vanguard Laboratory · V260204-5 002
Read this document note
Sample is labeled 30 mg and reported quantity is 40.30 mg. Report date is February 13, 2026, while the chromatogram filename visibly includes February 14, 2026. Do not label this as a conforming 30 mg inventory test.
- Sample
- Tirzepatide 30 mg
- Sample specification
- 30 mg
- Laboratory shown
- Vanguard Laboratory
- Submitting client shown
- Aevitas Research
- Report number
- V260204-5 002
- Sample lot / batch
- 260121-BZT-TR30-01-P
- Date reported
- 2026-02-13
| Test shown | Method shown | Reported result |
|---|---|---|
| Chromatographic Purity | HPLC-UV/VIS | >99.80% ± 0.18% |
| Quantity | HPLC-UV/VIS | 40.30 mg |
Results are transcribed from this sample report. The original document takes precedence; these results are not specifications or guarantees for other samples.
The submitting client is Aevitas Research. The connection between this sample lot and current NorthVerity inventory has not been established. Request the current lot document with your inquiry.
Related catalog entries
The links below are references based on catalog naming. Confirm the chemical form, blend composition, specification and current inventory lot separately.
Original-file fingerprint
SHA-256: f877bc92f862905d6b4d6a7839242bf49e00ee1343db7fcbedde00e307a5e3e7